Bengaluru: 08-April- 2025: GE HealthCare, a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, in collaboration with Jivika Foundation and Family Planning Association (FPA) India, successfully launched the Cervical Cancer-Free Mahadevapura Block initiative at Ramagondanahalli Government School, Mahadevapura Block, Bengaluru.
This transformative program is dedicated to vaccinating all girls aged 9-14 years across government schools in Mahadevapura Block against Human Papillomavirus (HPV), a leading cause of cervical cancer. By enabling early and preventive intervention, the initiative marks a significant step in advancing public health and reducing cervical cancer incidence.
The launch event was attended by esteemed dignitaries, partners, and community representatives, underscoring the collective commitment to safeguarding the health of young girls and strengthening public health infrastructure in the region.
Highlighting the importance of prevention and early vaccination, Chaitanya Sarawate – President & CEO-India & South Asia, GE HealthCare said, “HPV Types 16 and 18 accounts for nearly 77% of cervical cancer incidence in India. Prevention is the need of the hour. HPV vaccines work best if administered prior to exposure to HPV. With this Cervical Cancer Vaccination drive, we will ensure that 1400 adolescent girls are protected from this cancer. At GE HealthCare, as we aim to make healthcare limitless for all. This drive will help us spread awareness about HPV & cervical cancer, encourage early detection and reduce incidence of this terrible disease in our communities.”
Jignesh Patel, Director, Jivika Foundation added, “Jivika Foundation is proud to lead this initiative and collaborate with key stakeholders in the healthcare sector. Our vision is to make HPV vaccination accessible to all, eliminating cervical cancer from India, one block at a time.”